MENTINOVA, INC. is a biotechnology startup founded in 2013 and based in the United States. The company is focused on developing an oral medication to help treat symptoms of Parkinson’s disease. It received a significant $500.00K Venture Round investment on 28 January 2013, with the backing of Foundation Venture Capital Group.
This investment not only underscores the confidence of Foundation Venture Capital Group in MentiNova's innovative approach but also highlights the potential of the startup's solution for addressing a critical healthcare need. The developments in biotechnology, particularly in the realm of neurological disorders, are gaining increasing attention from investors due to their potential for significant social impact and commercial viability. Consequently, MentiNova's recent funding round positions it favorably within the dynamic landscape of biotech startups, setting the stage for further growth and development.
MENTINOVA, INC.
MentiNova Inc., which is developing an oral medication to help treat symptoms of Parkinson’s disease.
Founded 2013
New Brunswick, United States
1 employees
Venture round
Total: $500.00K
Biotechnology, Health and Wellness
New Brunswick, United States
1 employees
Venture round
Total: $500.00K
Biotechnology, Health and Wellness
General Information
Company Name
MENTINOVA, INC.
Founded Year
2013
Location
New Brunswick, United States
New Brunswick, United States
Employees
1
Industries
Biotechnology, Health and Wellness
Funding Stage
Venture round
Social
BounceWatch is an independent company data service, not affiliated with MENTINOVA, INC.. To contact MENTINOVA, INC., visit mentinova.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does MENTINOVA, INC. compare?
A PDF of MENTINOVA, INC. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting MENTINOVA, INC. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is MENTINOVA, INC. on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About MENTINOVA, INC.
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $500.00K | 1 |
|
28 Jan 2013 |
MENTINOVA, INC. Alternatives & Competitors
View All Alternatives
MENTINOVA, INC. vs
VAXIMM AG
Switzerland
Developing innovative oral T-cell immunotherapies to treat cancer patients
Grant
4 employees
Biotechnology, Health and Wellness
MENTINOVA, INC. vs
Aspen Neuroscience, Inc.
United States
Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS...
Series C
128 employees
Biotechnology, Health and Wellness
MENTINOVA, INC. vs
Veana Therapeutics, Inc.
United States
Veana Therapeutics, Inc is a clinical stage biopharma company developing oral mitochondrial Inhibito...
Grant
4 employees
Biotechnology, Health Care
FAQ About MENTINOVA, INC.
MentiNova Inc., which is developing an oral medication to help treat symptoms of Parkinson’s disease.
MENTINOVA, INC. was founded in 2013.
MENTINOVA, INC. is headquartered in New Brunswick, United States.
MENTINOVA, INC. operates in Biotechnology and Health and Wellness.
MENTINOVA, INC. has approximately 1 employees.
MENTINOVA, INC. has completed 1 funding round, raising a total of $500.00K. The latest funding stage is Venture round.
Top alternatives and competitors to MENTINOVA, INC. include VAXIMM AG, Aspen Neuroscience, Inc., Veana Therapeutics, Inc., Kantum Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MENTINOVA, INC. and VAXIMM AG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for MENTINOVA, INC., https://bouncewatch.com/company/mentinova-inc, updated 14 January 2025. When citing, please name BounceWatch and link this page.
